IL6 and chronic myelogenous leukemia, BCR-ABL1 positive: As depicted in Figure 3D, 37.2% IHC stained area corresponding to the IL-6 production was noticed in the hepatic tissue of the PBS-injected and CML-injected groups, respectively.